tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Facephi Gains Buy Ratings from JB Capital and Marex

Facephi Gains Buy Ratings from JB Capital and Marex

Facephi Biometria SA (ES:FACE) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Facephi Biometría SA has attracted positive attention from JB Capital and Marex, both of which have started coverage of its stock with a Buy recommendation. JB Capital set a target price of €2.0, while Marex targets €2.1, reflecting strong confidence in the company’s financial and operational potential. This move aligns with Facephi’s commitment to transparency and market engagement.

For further insights into ES:FACE stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1